859210-29-0Relevant academic research and scientific papers
1'-CYANO NUCLEOSIDE ANALOGS AND USES THEREOF
-
Paragraph 00411-00412, (2022/01/04)
Compounds and methods of using said compounds, singly or in combination with additional agents, and pharmaceutical compositions of said compounds for the treatment of viral infections are disclosed.
ANTIVIRAL COMPOUNDS
-
Paragraph 0340, (2021/08/27)
The present disclosure describes 4'-fluoromethyl nucleosides for treating viral infections, including Dengue.
PRODRUG OF HCV NS5B POLYMERASE INHIBITOR AND METHOD FOR PRODUCING AND USING SAME
-
Paragraph 0049; 0051, (2018/11/21)
The present invention relates to a prodrug and application thereof for the treatment of hepatitis C virus in patients. The prodrug of general formula 1, its stereoisomer, isotopically enriched analog, or crystalline or polymorphic form,
ANTIVIRAL COMPOSITION AND METHOD FOR USING SAME
-
Paragraph 0050; 0052, (2018/11/27)
The present invention relates to an antiviral composition and a method for application thereof in the treatment of hepatitis C virus. Said antiviral composition comprises the HCV NS5B inhibitor of general formula 1, or a stereoisomer, an isotopically enriched analog, or crystalline or polycrystalline forms thereof.
ANTIVIRAL OXIME PHOSPHORAMIDE COMPOUNDS
-
Page/Page column 32; 33; 34, (2017/07/06)
Compounds of Formula I: I and their pharmaceutically acceptable salts are useful for the inhibition of HIV reverse transcriptase. The compounds may also be useful for the prophylaxis or treatment of infection by HIV and in the prophylaxis, delay in the onset or progression, and treatment of AIDS. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antiviral agents, immunomodulators, antibiotics or vaccines.
